The Patent Finder

Kumho HT, Inc.

Also on record
Records under this name other than the patents Kumho HT, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.

Showing 1 to 5 of 5 · Back to Kumho HT, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,622,560Monoclonal antibody specific for CD43 epitope
Term ended
Term ended May 20, 2026 · USPTO record
Term endedTerm ended May 20, 2026USPTO record
US 8,753,636Acute leukemia and lymphoblastic lymphoma-specific CD43 epitope and use thereof
Term ended
Term ended Dec 20, 2025 · USPTO record
Term endedTerm ended Dec 20, 2025USPTO record
US 9,746,474Acute leukemia and lymphoblastic lymphoma-specific CD43 epitope and use thereof
Lapsed on the fee record
Ended Aug 29, 2025 · USPTO record
Lapsed on the fee recordEnded Aug 29, 2025USPTO record
US 8,426,555Acute leukemia and lymphoblastic lymphona-specific CD43 epitope
Lapsed on the fee record
Ended Apr 23, 2025 · USPTO record
Lapsed on the fee recordEnded Apr 23, 2025USPTO record
US 8,404,812Epitope of CD66C specific to lung adenocarcinoma and antibody recognizing the same
Lapsed on the fee record
Ended Mar 26, 2025 · USPTO record
Lapsed on the fee recordEnded Mar 26, 2025USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited